Hussman Strategic Advisors, Inc. Neogenomics Inc Transaction History

Hussman Strategic Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$12.15 - $17.85 $318,937 - $468,562	26,250 New	26,250 $322,000
Q3 2020 Nov 02, 2020	SELL	$33.26 - $40.48 $665,200 - $809,599	-20,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$24.21 - $31.02 $121,050 - $155,100	-5,000 Reduced 20.0%	20,000 $620,000
Q4 2019 Jan 31, 2020	SELL	$18.96 - $29.84 $1.42 Million - $2.24 Million	-75,000 Reduced 75.0%	25,000 $731,000
Q2 2019 Jul 31, 2019	SELL	$19.57 - $24.1 $1.96 Million - $2.41 Million	-100,000 Reduced 50.0%	100,000 $2.19 Million
Q3 2018 Oct 31, 2018	BUY	$12.5 - $15.38 $625,000 - $769,000	50,000 Added 33.33%	200,000 $3.07 Million
Q2 2018 Jul 31, 2018	BUY	$7.99 - $14.05 $1.2 Million - $2.11 Million	150,000 New	150,000 $1.97 Million

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.